4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-23-070012
Options or other derivatives
- President and COO acquired 260,000 shares (grant or award)
From the SEC's structured data for this filing
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-23-070012
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…